Moran鈥檚 David Krizaj, PhD, has identified a new protein that regulates intraocular pressure in glaucoma and is designing a potentially sight-saving treatment.
Mary Elizabeth Hartnett, MD, and colleagues at the John A. Moran Center and Department of Pediatrics at the University of Utah and Children鈥檚 Hospital of Wisconsin, were looking for a...
NIH-funded research provides framework for future studies of AMD biology, therapy An international study of about 43,000 people has significantly expanded the number of genetic factors known to play a...
Glaucoma is caused by increased pressure in the eye. Dr. David Krizaj has discovered that we can block those pressure sensors with pressure-reducing drugs, and we could protect cells from...
Research to Prevent Blindness, a New York-based foundation, has announced that University of Utah researcher Wolfgang Baehr, PhD, will receive the Nelson Trust Award for Retinitis Pigmentosa and an accompanying...
The University of Utah's Mary Elizabeth Hartnett, MD, has a full calendar at this week's Association for Research in Vision and Ophthalmology annual meeting in Orlando. She is organizing and...
Jun Yang, PhD, an assistant professor of ophthalmology and visual sciences at the University of Utah School of Medicine and researcher at the John. A. Moran Eye Center, is committed...
The American Journal of Pathology, the leading global forum for reporting quality original research on cellular and molecular mechanisms of disease, has published a research paper originating from the John...
A University of Utah researcher and ophthalmologist helped confirm important findings from a group of Icelandic scientists who uncovered a rare risk locus for age-related macular degeneration (AMD).
A new study published by The University of Utah's John A. Moran Eye Center highlights significant progress toward isolating the underlying causes of retinopathy of prematurity (ROP), a condition that...